Quantification of ligand PET studies using a reference region with a displaceable fraction: application to occupancy studies with [(11)C]-DASB as an example

J Cereb Blood Flow Metab. 2012 Jan;32(1):70-80. doi: 10.1038/jcbfm.2011.108. Epub 2011 Aug 3.

Abstract

This paper aims to build novel methodology for the use of a reference region with specific binding for the quantification of brain studies with radioligands and positron emission tomography (PET). In particular: (1) we introduce a definition of binding potential BP(D)=DVR-1 where DVR is the volume of distribution relative to a reference tissue that contains ligand in specifically bound form, (2) we validate a numerical methodology, rank-shaping regularization of exponential spectral analysis (RS-ESA), for the calculation of BP(D) that can cope with a reference region with specific bound ligand, (3) we demonstrate the use of RS-ESA for the accurate estimation of drug occupancies with the use of correction factors to account for the specific binding in the reference. [(11)C]-DASB with cerebellum as a reference was chosen as an example to validate the methodology. Two data sets were used; four normal subjects scanned after infusion of citalopram or placebo and further six test-retest data sets. In the drug occupancy study, the use of RS-ESA with cerebellar input plus corrections produced estimates of occupancy very close the ones obtained with plasma input. Test-retest results demonstrated a tight linear relationship between BP(D) calculated either with plasma or with a reference input and high reproducibility.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aniline Compounds / pharmacokinetics*
  • Binding, Competitive
  • Carbon Radioisotopes
  • Cerebellum / diagnostic imaging*
  • Cerebellum / metabolism
  • Citalopram / pharmacokinetics
  • Humans
  • Ligands
  • Linear Models
  • Male
  • Middle Aged
  • Models, Biological
  • Positron-Emission Tomography / methods*
  • Protein Binding
  • Radioligand Assay
  • Radiopharmaceuticals / pharmacokinetics*
  • Reference Values
  • Reproducibility of Results
  • Selective Serotonin Reuptake Inhibitors / pharmacokinetics
  • Serotonin Plasma Membrane Transport Proteins / metabolism
  • Sulfides / pharmacokinetics*
  • Tissue Distribution

Substances

  • 3-amino-4-(2-dimethylaminomethylphenylsulfanyl)benzonitrile
  • Aniline Compounds
  • Carbon Radioisotopes
  • Ligands
  • Radiopharmaceuticals
  • Serotonin Plasma Membrane Transport Proteins
  • Serotonin Uptake Inhibitors
  • Sulfides
  • Citalopram